New York Life Investment Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.3M | Buy |
38,900
+294
| +0.8% | +$131K | 0.16% | 122 |
|
|
2025
Q1 | $18.7M | Sell |
38,606
-454
| -1% | -$220K | 0.19% | 111 |
|
|
2024
Q4 | $15.7M | Buy |
39,060
+383
| +1% | +$154K | 0.15% | 122 |
|
|
2024
Q3 | $18M | Sell |
38,677
-789
| -2% | -$367K | 0.17% | 113 |
|
|
2024
Q2 | $18.5M | Buy |
39,466
+401
| +1% | +$188K | 0.19% | 113 |
|
|
2024
Q1 | $16.3M | Sell |
39,065
-1,344
| -3% | -$562K | 0.16% | 118 |
|
|
2023
Q4 | $16.4M | Sell |
40,409
-7,342
| -15% | -$2.99M | 0.17% | 115 |
|
|
2023
Q3 | $16.6M | Sell |
47,751
-1,444
| -3% | -$502K | 0.18% | 111 |
|
|
2023
Q2 | $17.3M | Sell |
49,195
-235
| -0.5% | -$82.7K | 0.18% | 117 |
|
|
2023
Q1 | $15.6M | Sell |
49,430
-3,076
| -6% | -$969K | 0.17% | 127 |
|
|
2022
Q4 | $15.2M | Sell |
52,506
-242
| -0.5% | -$69.9K | 0.17% | 138 |
|
|
2022
Q3 | $15.3M | Sell |
52,748
-792
| -1% | -$229K | 0.18% | 121 |
|
|
2022
Q2 | $15.1M | Buy |
+53,540
| New | +$15.1M | 0.18% | 122 |
|